• Key components:
o Neutrophils: first responders; phagocytosis and microbial killing.
o Macrophages: phagocytosis, antigen presentation, cytokine release.
o Natural Killer (NK) cells: recognize and kill virus-infected and tumour cells;
do not require antigen presentation.
o Complement system:
Classical pathway (antibody-mediated), alternative, lectin pathways.
Functions: opsonisation (C3b), chemotaxis (C5a), cell lysis (MAC – C5b-9).
• Features:
o Rapid, non-specific response.
o No immunological memory.
• B cells (Humoral immunity)
o Produce antibodies.
o Differentiate into plasma cells and memory B cells.
• T cells (Cell-mediated immunity)
o CD4+ (helper T cells): recognize MHC II; activate B cells, macrophages.
o CD8+ (cytotoxic T cells): recognize MHC I; kill infected cells directly.
• MHC (Major Histocompatibility Complex)
o Class I: all nucleated cells; present to CD8+ T cells.
o Class II: antigen-presenting cells (APCs); present to CD4+ T cells.
Class Key Features
IgG Most abundant, crosses placenta, opsonisation, complement activation
IgA Mucosal surfaces (gut, saliva, tears, breast milk)
IgM First produced (primary response), pentameric, good at complement activation
IgE Allergic reactions, parasite defence
IgD Mainly on B cell surface (B cell receptor role)
Type Mechanism Examples
I IgE-mediated (immediate) Anaphylaxis, urticaria, asthma
II Antibody-mediated cytotoxic Goodpasture’s, autoimmune haemolytic anaemia
III Immune complex-mediated SLE, post-streptococcal GN
IV T cell-mediated (delayed) Contact dermatitis, TB Mantoux test
• Central tolerance: deletion of autoreactive T and B cells in thymus and bone marrow.
• Peripheral tolerance: anergy, suppression (regulatory T cells), ignorance.
• Autoimmunity: breakdown of tolerance → self-reactive immune responses.
o Genetic predisposition (e.g., HLA associations).
o Environmental triggers (e.g., infections, smoking).
• Rejection types:
o Hyperacute: minutes to hours; preformed anti-donor antibodies
(e.g., ABO incompatibility); complement-mediated.
o Acute: days to weeks; T cell-mediated response against donor MHC.
o Chronic: months to years; chronic low-grade immune injury, vascular changes, fibrosis.
• Graft-versus-host disease (GVHD):
o Donor T cells attack recipient tissues.
o Seen in bone marrow transplantation.
Extra Revision Pearls
• HLA-B27: associated with seronegative spondyloarthropathies.
• HLA-DR3/DR4: linked to type 1 diabetes, autoimmune thyroid disease.
• C1 esterase inhibitor deficiency → hereditary angioedema (non-itchy swelling, no urticaria).
• Complement deficiencies: predispose to Neisseria infections.
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.